JUISCI | Medical Discovery App | Med Community

🍋 Explore this study and more on the Juisci app app.juisci.com/post/genomic-t…

🧬 Precision #oncology improves survival, but only when backed by robust evidence. A cohort study (n=3,383, JAMA Oncology) shows benefit only for biomarker–drug pairs supported by prospective trials. No benefit for investigational or repurposed matches. 👉 Evidence matters. #MedEd #Genomics

Pour les professionnels de santé francophones 🇫🇷, certaines publications sont également disponibles en français dans l’application Juisci. 👇 Découvrir dans l’app app.juisci.com

🆕 Insights in #BreastCancer radiotherapy. The phase 3 UNICANCER HypoG-01 trial shows that for patients with early breast cancer requiring nodal irradiation, a 3-week hypofractionated radiotherapy schedule provides safety and lymphoedema risk comparable to standard 5-week treatment. These findings support integrating shorter radiotherapy schedules into routine care. 👉 Stay up to date with the latest medical research app.juisci.com #Radiotherapy #ClinicalResearch #MedEd

Pour les professionnels de santé francophones 🇫🇷, certaines publications sont également disponibles en français dans l’application Juisci. 👇 Découvrir dans l’app app.juisci.com

🧠 Could a lumbar puncture help diagnose Lewy body dementia ? A Nature Medicine study suggests that CSF DOPA-decarboxylase levels may help distinguish patients with Lewy body dementia and Parkinson’s disease from other neurological conditions. Explore the full digest on Juisci app.juisci.com #Neurology #ParkinsonsDisease #ClinicalResearch

Cet espace reflète un engagement commun : faciliter l’accès à une information scientifique pertinente et fondée sur les preuves, afin de soutenir la pratique clinique et améliorer la prise en charge des patients atteints de maladies rénales. 👇 Découvrir l'espace CSL Vifor : app.juisci.com/room/discovery…

🩺 Journée mondiale du #Rein En cette journée mondiale du Rein, Juisci met en lumière son espace dédié à la #Néphrologie. Développé en collaboration avec @cslvifor

🇫🇷 Pour les #radiologues francophones, la playlist Radiologie & Imagerie médicale est également accessible dans l’application Juisci. Une sélection de publications clés pour suivre plus facilement les évolutions du domaine : imagerie, IA, nouvelles technologies et recherche clinique. 👇 Découvrir la playlist app.juisci.com/playlist/publi…

#Radiologists are surrounded by more #scientificknowledge than ever. Thousands of publications, evolving guidelines, new imaging technologies and rapidly developing AI tools. On Juisci, we curate key research into playlists. 𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝗼𝘂𝗿 𝗿𝗮𝗱𝗶𝗼𝗹𝗼𝗴𝘆 & 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗶𝗺𝗮𝗴𝗶𝗻𝗴 𝗽𝗹𝗮𝘆𝗹𝗶𝘀𝘁 👇 app.juisci.com/playlist/publi… #Radiology #MedEd #AIinHealthcare #ECR2026

After #ECR2026, one thing is clear : #Radiology is changing fast. #AI → entering #clinical workflows Imaging tech → accelerating #Scientificknowledge → exploding Here are 8 insights that stood out in Vienna. 👇

Coming soon : 8 insights from ECR 🩻

𝗥𝗮𝗱𝗶𝗼𝗹𝗼𝗴𝘆 𝗶𝘀 𝗯𝗲𝗰𝗼𝗺𝗶𝗻𝗴 𝗼𝗻𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗺𝗼𝘀𝘁 𝗱𝗮𝘁𝗮-𝗶𝗻𝘁𝗲𝗻𝘀𝗶𝘃𝗲 𝘀𝗽𝗲𝗰𝗶𝗮𝗹𝘁𝗶𝗲𝘀 𝗶𝗻 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲. At #ECR2026 in Vienna, one question kept coming up in conversations with clinicians : How do you stay up to date with the explosion of scientific knowledge ?

@Future4care Last minute? Tickets here 👇 2026.future4care.com/en/future4care…

📍 Live from @Future4care European #DemoDay 🇪🇺🧪 If you’re in Paris and building in #healthtech let’s connect. See you there 👋

@Future4care More info 👇 2026.future4care.com/en/future4care…

🚀Join us at Europe’s leading #Healthtech Demo Day, March 12 at @Future4care ! If you’re building in prevention, care or drug development > let’s connect in Paris 🧪🤝#EuropeanDemoDay #Future4care

AAV9 β-galactosidase gene therapy in GM1 gangliosidosis. Phase 1–2 data suggest potential disease-modifying effects — but safety monitoring remains critical. What do the results really show? Full breakdown in the Juisci app 👇 app.juisci.com/post/aav9-gene…